SHOGUN GW-501516 (Cardarine) 10mg X 60 Units For Sale.

SHOGUN GW-501516 (Cardarine) 10mg X 60 Units, commonly known as Cardarine, is a PPARδ receptor agonist developed in the 1990s by Ligand Pharmaceuticals and GlaxoSmithKline (GSK) for potential treatment of metabolic and cardiovascular diseases. Each unit contains 10 mg of GW-501516, with 60 units per package.

Safety Concerns and Side Effects:

Despite initial promise, further research revealed serious safety concerns:

• Carcinogenic Risks: Studies have shown that GW-501516 can induce rapid development of cancers in multiple organs, including the liver, stomach, tongue, skin, bladder, ovaries, uterus, and testes in animal models.

• Regulatory Warnings: The World Anti-Doping Agency (WADA) added GW-501516 to its list of prohibited substances in 2009 due to health risks, including carcinogenicity.

Legal Status:

GW-501516 is classified as a research chemical and is not approved for human consumption by regulatory authorities such as the FDA. Its use is banned by WADA in competitive sports. Regulations may vary by region, so it’s essential to be aware of local laws and guidelines.

Important Notice:

SHOGUN GW-501516 is sold for research purposes only and is not intended for human consumption. The information provided here is for educational purposes and should not be construed as medical advice. Always consult with a qualified healthcare professional before considering the use of any research chemical.

Given the significant health risks, including carcinogenicity, individuals should exercise extreme caution and thoroughly consider potential dangers before any exposure to GW-501516.